Sittner & Nelson’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28K | Hold |
75
| – | – | ﹤0.01% | 464 |
|
|
2025
Q1 | $4.79K | Hold |
75
| – | – | ﹤0.01% | 405 |
|
|
2024
Q4 | $9.12K | Hold |
75
| – | – | ﹤0.01% | 356 |
|
|
2024
Q3 | $9.37K | Hold |
75
| – | – | ﹤0.01% | 348 |
|
|
2024
Q2 | $11.9K | Hold |
75
| – | – | 0.01% | 334 |
|
|
2024
Q1 | $9.71K | Hold |
75
| – | – | ﹤0.01% | 346 |
|
|
2023
Q4 | $7.23K | Hold |
75
| – | – | ﹤0.01% | 366 |
|
|
2023
Q3 | $9.09K | Hold |
75
| – | – | 0.01% | 347 |
|
|
2023
Q2 | $8.59K | Buy |
75
+25
| +50% | +$2.86K | ﹤0.01% | 353 |
|
|
2023
Q1 | $6.89K | Hold |
50
| – | – | ﹤0.01% | 381 |
|
|
2022
Q4 | $6.48K | Hold |
50
| – | – | ﹤0.01% | 373 |
|
|
2022
Q3 | $6K | Hold |
50
| – | – | ﹤0.01% | 374 |
|
|
2022
Q2 | $4K | Hold |
50
| – | – | ﹤0.01% | 424 |
|
|
2022
Q1 | $4K | Hold |
50
| – | – | ﹤0.01% | 397 |
|
|
2021
Q4 | $5K | Hold |
50
| – | – | ﹤0.01% | 385 |
|
|
2021
Q3 | $5K | Hold |
50
| – | – | ﹤0.01% | 358 |
|
|
2021
Q2 | $4K | Hold |
50
| – | – | ﹤0.01% | 346 |
|
|
2021
Q1 | $4K | Hold |
50
| – | – | ﹤0.01% | 348 |
|
|
2020
Q4 | $9K | Buy |
+50
| New | +$9K | 0.01% | 294 |
|